TrendFlares logo

Cue Biopharma, Inc. (CUE)

$0.56 2.04% $0.01 Healthcare

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-102, a fusion protein biologic to target and activate antigen-specific T cells to fight cancers; CUE-103 a CUE-100 series Immuno-STAT targeting the KRAS G12V mutation, including colorectal carcinoma, lung cancer, and pancreatic cancer; CUE-200 that focuses on cell surface receptors, including CD80 and/or 4-1BBL to address T cell exhaustion associated with chronic infections; and CUE-300 and CUE-400 framework to target various autoimmune diseases. Cue Biopharma, Inc. has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; LG Chem Life Sciences for the development of Immuno-STATs focused on the field of oncology; and Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

$27.48M

Mr. Daniel R. Passeri J.D., M.Sc., MSc.

57.00

Cambridge, MA

Jan 02, 2018

-0.58

$-0.97

1.82

2.06

-566.02%

-0.60

-0.02

1.31

3.31

2.06

-110.93%

-142.93%

Downtrend

Similar stocks (16)

Day One Biopharmaceuticals, Inc.

DAWN

$14.32 3.84%
Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.04 -1.67%
Uptrend

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76%
Uptrend

TScan Therapeutics, Inc.

TCRX

$5.64 1.81%
Downtrend

HOOKIPA Pharma Inc.

HOOK

$4.72 2.16%
Downtrend

Fennec Pharmaceuticals Inc.

FENC

$5.29 1.34%
Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.71 0.63%
Downtrend

Anixa Biosciences, Inc.

ANIX

$3.42 -0.87%
Neutral

INmune Bio, Inc.

INMB

$5.33 2.70%
Downtrend

Coya Therapeutics, Inc.

COYA

$6.22 2.64%
Downtrend

Lantern Pharma Inc.

LTRN

$4.07 4.09%
Downtrend

Cognition Therapeutics, Inc.

CGTX

$0.61 1.72%
Downtrend

IN8bio, Inc.

INAB

$0.32 -2.70%
Downtrend

TFF Pharmaceuticals, Inc.

TFFP

$2.31 1.32%
Downtrend

Galera Therapeutics, Inc.

GRTX

$0.08 -0.63%
Downtrend

Dermata Therapeutics, Inc.

DRMA

$1.75 -22.22%
Downtrend

ETF Exposure (14)

ETFMG Treatments, Testing and Advancements ETF

GERM

0.07%

$19.16 -0.29%
Uptrend

iShares Micro-Cap ETF

IWC

0.00809%

$126.54 2.19%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

1.0926e-4%

$65.11 2.13%
Uptrend

Dimensional U.S. Equity ETF

DFUS

2.6969999999999998e-5%

$61.75 1.80%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

1.476e-5%

$34.14 1.82%
Uptrend

Dimensional US Sustainability Core 1 ETF

DFSU

9.100000000000001e-7%

$36.98 1.93%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend